FDA Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Request for Comments

 
Docket ID: FDA-2012-N-1148
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
RIN: Not Assigned
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Short Title: Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Request for Comments
Keyword(s): cder, nicotine, cder2012196, Smoking-Cessation , Congress, innovative products , tobacco, dependence, smoking prevention , Tobacco Control Act, non-nicotine, therapy
Type: Rulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: N
 

Primary Documents

View All  (2)
Comment Period Closed
Jan 16, 2013 11:59 PM ET
Proposed Rule
Posted: 01/03/2013
ID: FDA-2012-N-1148-0011
Comment Period Closed
Jan 02, 2013 11:59 PM ET
Proposed Rule
Posted: 11/28/2012
ID: FDA-2012-N-1148-0001

Supporting Documents

View All  (2)
Comments Not Accepted
Supporting & Related Material
Posted: 12/20/2012
ID: FDA-2012-N-1148-0005
Comments Not Accepted
Supporting & Related Material
Posted: 12/20/2012
ID: FDA-2012-N-1148-0004

Comments

View All  (116)

5,357
Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.